Symbiotec Pharmalab IPO GMP ₹185 Today (13 Oct), Price Band, Allotment Date

Symbiotec Pharmalab IPO is a Mainboard issue open from 24–27 August. The company is raising ₹1,757 Cr at a price band of ₹938 to ₹988 per share.

Symbiotec Pharmalab IPO GMP (grey market premium)

₹185

Implied listing gain: ₹988

On the GMP figure: grey market premium is quoted by informal dealers. No exchange publishes it, no regulator oversees it, and it is not a forecast of the listing price. Issues quoting a strong premium have listed below their issue price. Weigh the financials and the risk factors in the RHP well above this number.

Symbiotec Pharmalab IPO Review & Analysis

Our reading of the numbers below — growth rates, margins, pricing and demand are calculated from the company's own filed figures, not copied from anywhere.

GMP-implied listing gain

+18.7%

₹185 premium on a ₹988 issue price

Symbiotec Pharmalab is a mainboard issue raising ₹1,757 Cr, offered in a band of ₹938–₹988 per share.

A grey market premium of ₹185 on the upper band of ₹988 implies a listing gain of roughly 18.7%. The grey market is unofficial and unregulated, the premium can change daily, and it has no bearing on allotment — treat it as a sentiment reading, not a forecast.

The figures above are worked out from the issue's own filed numbers and are for information only. They are not investment advice — read the RHP before you apply.

IPO Date	24–27 August
Face Value	Per Share
Price Range	₹938 to ₹988
Issue Size	₹1,757 Cr
Lot Size	Shares
Allotment Date
Listing Date
Registrar

Quota Allocation

Category	Allocation
Retail Investors
QIB (Qualified Institutional Buyers)
HNI (High Net Worth Individuals)

Symbiotec Pharmalab IPO — common questions

What is Symbiotec Pharmalab IPO?

Symbiotec Pharmalab IPO is a Mainboard issue open from 24–27 August. The company is raising ₹1,757 Cr at a price band of ₹938 to ₹988 per share.

When does Symbiotec Pharmalab IPO open and close?

The issue is open 24–27 August. Bids must be placed, and any UPI mandate approved, before the cut-off on the closing day.

What is the Symbiotec Pharmalab IPO price band?

The price band is ₹938 to ₹988 per equity share. Retail investors may bid at cut-off, meaning they accept the final discovered price within this band.

What is the Symbiotec Pharmalab IPO issue size?

The total issue size is ₹1,757 Cr.

Investment Disclaimer

This information is for educational purposes only. Please conduct your own research and consult with financial advisors before making investment decisions. IPO investments carry market risks.